Universität zu Köln

Zander, Thomas and Hallek, Michael ORCID: 0000-0002-7425-4455 (2022). What should specialist in internal medicine be aware of in patients treated with biologics? Infections and autoimmune phenomena. Internist, 63 (2). S. 165 - 171. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Full text not available from this repository.

Abstract

Biologics that influence the immune system play a crucial role in the treatment of autoimmune and malignant diseases. Overall these drugs have revolutionized treatment as they demonstrate high efficacy and a relatively low amount of side effects. This leads to longer treatment of patients with a high quality of life. Side effects, especially longer-term side effects, become ever more important as patients are simultaneously seen by different physicians due to comorbidities. Infections, mainly of the upper airway or urogenital tract, represent the main side effect of immunosuppressive biologics, but atypical infections by fungi or mycobacteria may also occur. Biologics that enhance the immune response such as checkpoint inhibitors lead to autoimmune phenomena necessitating the interruption of treatment or immunosuppressive treatment.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Zander, Thomas UNSPECIFIED UNSPECIFIED UNSPECIFIED Hallek, Michael UNSPECIFIED orcid.org/0000-0002-7425-4455 UNSPECIFIED
URN:	urn:nbn:de:hbz:38-657860
DOI:	10.1007/s00108-021-01259-8
Journal or Publication Title:	Internist
Volume:	63
Number:	2
Page Range:	S. 165 - 171
Date:	2022
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1432-1289
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language HYPERSENSITIVITY REACTIONS; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; IMMUNE; SAFETY; RISK; IPILIMUMAB; MANAGEMENT; NIVOLUMAB; THERAPY Multiple languages Medicine, General & Internal Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/65786